Sommer A., Hermawan A., Martina Mickler F., Ljepoja B., Knyazev P., Bräuchle C., Ullrich A., Wagner E., Roidl A. Salinomycin co-treatment enhances tamoxifen cytotoxicity in luminal A breast tumor cells by facilitating lysosomal degradation of receptor tyrosine kinases. Oncotarget. 2016; 7: 50461-50476. Retrieved from https://www.oncotarget.com/article/10459/